Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters
Aquavit Pharmaceuticals, Inc. Names Timothy Sherwood Chief Operating Officer

AAD, Industry Collab to Increase Number of Black,Latino, and Indigenous Physicians in Dermatology
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

Aquavit Further Prevails Against Counterfeiters in U.S. Following its Recent Victory in Europe
Aquavit's AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO

Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions
Aquavit to Introduce A New Botulinum Toxin (DTX-021)
New Vitamin Supplement Compositions Patent Granted by USPTO


Dr. Sten Vermund, Dean, Yale School of Public Health Congratulates Aquavit Pharmaceuticals
Aquavit Wins Trademark Case over AQUAGOLD in European Union Intellectual Property Office
The New Normal: Protect Yourself with Face Masks, & Protect Your Skin with the InnerB System® Mask
Aquavit files patent for an innovative method for delivering exosomes using microchannel technology
Aquavit Pharmaceuticals, Inc. Wins Default Judgement Against Counterfeiter
Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters
Aquavit files patent for a unique method to treat Macular Degeneration


Aquavit Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International Conference
New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer